MITHRACIN vs ZOMETA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. MITHRACIN and ZOMETA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MITHRACIN	ZOMETA
Rating	64/100	70/100
Pharmacy pays	—	$0.47 /mL
Type	RX	RX
Active ingredient	PLICAMYCIN	ZOLEDRONIC ACID
Manufacturer	Pfizer	Novartis
Dosage forms	Injectable	Injectable
Drug class	—	Bisphosphonate
Boxed warning	None	None
Treats	Hypercalcemia, Extramammary Paget Disease, Testicular Neoplasms	Bone Neoplasms, Hypercalcemia, Multiple Myeloma

mithracin zometa

Rating

64/100

70/100

Pharmacy pays

—

$0.47 /mL

Type

Active ingredient

PLICAMYCIN

ZOLEDRONIC ACID

Manufacturer

Pfizer

Novartis

Dosage forms

Injectable

Drug class

—

Bisphosphonate

Boxed warning

None

Treats

Hypercalcemia, Extramammary Paget Disease, Testicular Neoplasms

Bone Neoplasms, Hypercalcemia, Multiple Myeloma

Frequently asked questions

Which is better-rated, Mithracin or Zometa?

By our independent rating, Zometa scores higher — 3.5 vs 3.2 out of 5 for Mithracin. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mithracin and Zometa?

Mithracin contains Plicamycin, while Zometa contains Zoledronic Acid — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.